Excelsior Biopharma Stock Net Income
| 6496 Stock | TWD 29.50 0.45 1.55% |
Excelsior Biopharma fundamentals help investors to digest information that contributes to Excelsior Biopharma's financial success or failures. It also enables traders to predict the movement of Excelsior Stock. The fundamental analysis module provides a way to measure Excelsior Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Excelsior Biopharma stock.
Excelsior |
Excelsior Biopharma Company Net Income Analysis
Excelsior Biopharma's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Excelsior Biopharma Net Income | (15.65 M) |
Most of Excelsior Biopharma's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Excelsior Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Excelsior Biopharma reported net income of (15.65 Million). This is 104.59% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers-Specialty & Generic industry. The net income for all Taiwan stocks is 102.74% higher than that of the company.
Excelsior Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Excelsior Biopharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Excelsior Biopharma could also be used in its relative valuation, which is a method of valuing Excelsior Biopharma by comparing valuation metrics of similar companies.Excelsior Biopharma is currently under evaluation in net income category among its peers.
Excelsior Fundamentals
| Return On Equity | -0.0288 | |||
| Return On Asset | -0.0116 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 577.51 M | |||
| Shares Outstanding | 46.69 M | |||
| Shares Owned By Insiders | 61.00 % | |||
| Shares Owned By Institutions | 0.33 % | |||
| Price To Book | 1.09 X | |||
| Price To Sales | 1.51 X | |||
| Revenue | 1.34 B | |||
| Gross Profit | 293.35 M | |||
| EBITDA | 23.16 M | |||
| Net Income | (15.65 M) | |||
| Total Debt | 293.99 M | |||
| Book Value Per Share | 25.60 X | |||
| Cash Flow From Operations | 55.82 M | |||
| Earnings Per Share | (0.63) X | |||
| Number Of Employees | 23 | |||
| Beta | 0.74 | |||
| Market Capitalization | 1.32 B | |||
| Total Asset | 1.84 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 1.84 B |
About Excelsior Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Excelsior Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Excelsior Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Excelsior Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Excelsior Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Excelsior Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Excelsior Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Excelsior Stock
Moving against Excelsior Stock
The ability to find closely correlated positions to Excelsior Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Excelsior Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Excelsior Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Excelsior Biopharma to buy it.
The correlation of Excelsior Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Excelsior Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Excelsior Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Excelsior Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Excelsior Stock Analysis
When running Excelsior Biopharma's price analysis, check to measure Excelsior Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Excelsior Biopharma is operating at the current time. Most of Excelsior Biopharma's value examination focuses on studying past and present price action to predict the probability of Excelsior Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Excelsior Biopharma's price. Additionally, you may evaluate how the addition of Excelsior Biopharma to your portfolios can decrease your overall portfolio volatility.